vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Net Lease Office Properties (NLOP). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $30.7M, roughly 1.6× Net Lease Office Properties). Net Lease Office Properties runs the higher net margin — -0.2% vs -4.8%, a 4.6% gap on every dollar of revenue. On growth, Net Lease Office Properties posted the faster year-over-year revenue change (10.9% vs -47.3%). Over the past eight quarters, Net Lease Office Properties's revenue compounded faster (-16.4% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Net Lease Office Properties is a real estate investment entity focused on acquiring, owning, and operating high-quality single-tenant net lease office assets, primarily located across the United States. It delivers stable, long-term income streams to investors through its curated portfolio of commercial real estate holdings.
IRWD vs NLOP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $30.7M |
| Net Profit | $-2.3M | $-53.0K |
| Gross Margin | — | — |
| Operating Margin | 14.3% | -0.2% |
| Net Margin | -4.8% | -0.2% |
| Revenue YoY | -47.3% | 10.9% |
| Net Profit YoY | -200.9% | 99.9% |
| EPS (diluted) | $0.01 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $30.7M | ||
| Q3 25 | $122.1M | $29.8M | ||
| Q2 25 | $85.2M | $29.2M | ||
| Q1 25 | $41.1M | $29.2M | ||
| Q4 24 | $90.5M | $27.7M | ||
| Q3 24 | $91.6M | $31.5M | ||
| Q2 24 | $94.4M | $39.0M | ||
| Q1 24 | $74.9M | $44.0M |
| Q4 25 | $-2.3M | $-53.0K | ||
| Q3 25 | $40.1M | $-64.2M | ||
| Q2 25 | $23.6M | $-81.5M | ||
| Q1 25 | $-37.4M | $492.0K | ||
| Q4 24 | $2.3M | $-35.8M | ||
| Q3 24 | $3.6M | $-40.3M | ||
| Q2 24 | $-860.0K | $12.5M | ||
| Q1 24 | $-4.2M | $-27.8M |
| Q4 25 | 14.3% | -0.2% | ||
| Q3 25 | 61.8% | -215.2% | ||
| Q2 25 | 53.2% | -279.1% | ||
| Q1 25 | -70.7% | 2.0% | ||
| Q4 24 | 34.8% | -140.7% | ||
| Q3 24 | 28.0% | -126.4% | ||
| Q2 24 | 26.5% | 32.3% | ||
| Q1 24 | 14.7% | -62.7% |
| Q4 25 | -4.8% | -0.2% | ||
| Q3 25 | 32.8% | -215.4% | ||
| Q2 25 | 27.7% | -279.5% | ||
| Q1 25 | -90.9% | 1.7% | ||
| Q4 24 | 2.5% | -129.0% | ||
| Q3 24 | 4.0% | -128.0% | ||
| Q2 24 | -0.9% | 31.9% | ||
| Q1 24 | -5.6% | -63.3% |
| Q4 25 | $0.01 | $-0.01 | ||
| Q3 25 | $0.23 | $-4.33 | ||
| Q2 25 | $0.14 | $-5.50 | ||
| Q1 25 | $-0.23 | $0.03 | ||
| Q4 24 | $0.03 | $-2.41 | ||
| Q3 24 | $0.02 | $-2.73 | ||
| Q2 24 | $-0.01 | $0.84 | ||
| Q1 24 | $-0.03 | $-1.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $119.6M |
| Total DebtLower is stronger | — | $21.9M |
| Stockholders' EquityBook value | $-261.8M | $293.9M |
| Total Assets | $396.9M | $453.4M |
| Debt / EquityLower = less leverage | — | 0.07× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $119.6M | ||
| Q3 25 | $140.4M | $38.7M | ||
| Q2 25 | $92.9M | $54.1M | ||
| Q1 25 | $108.5M | $28.2M | ||
| Q4 24 | $88.6M | $25.1M | ||
| Q3 24 | $88.2M | $36.1M | ||
| Q2 24 | $105.5M | $36.1M | ||
| Q1 24 | $121.5M | $39.8M |
| Q4 25 | — | $21.9M | ||
| Q3 25 | $199.5M | $47.1M | ||
| Q2 25 | $199.3M | $117.2M | ||
| Q1 25 | $199.2M | $148.5M | ||
| Q4 24 | $199.0M | $169.2M | ||
| Q3 24 | $198.8M | $239.4M | ||
| Q2 24 | $198.6M | $327.4M | ||
| Q1 24 | $398.3M | $515.2M |
| Q4 25 | $-261.8M | $293.9M | ||
| Q3 25 | $-264.2M | $430.3M | ||
| Q2 25 | $-308.2M | $500.0M | ||
| Q1 25 | $-334.1M | $582.1M | ||
| Q4 24 | $-301.3M | $581.2M | ||
| Q3 24 | $-311.3M | $621.9M | ||
| Q2 24 | $-321.7M | $660.3M | ||
| Q1 24 | $-330.5M | $647.2M |
| Q4 25 | $396.9M | $453.4M | ||
| Q3 25 | $396.1M | $522.6M | ||
| Q2 25 | $342.9M | $668.7M | ||
| Q1 25 | $327.2M | $784.1M | ||
| Q4 24 | $350.9M | $805.1M | ||
| Q3 24 | $389.5M | $919.9M | ||
| Q2 24 | $395.6M | $1.0B | ||
| Q1 24 | $438.8M | $1.2B |
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.11× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.38× | ||
| Q2 24 | — | 0.50× | ||
| Q1 24 | — | 0.80× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $64.1M |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $64.1M | ||
| Q3 25 | $47.6M | $16.3M | ||
| Q2 25 | $-15.1M | $11.7M | ||
| Q1 25 | $20.0M | $14.1M | ||
| Q4 24 | $15.2M | $71.9M | ||
| Q3 24 | $9.9M | $20.3M | ||
| Q2 24 | $33.5M | $14.7M | ||
| Q1 24 | $45.0M | $26.4M |
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | 28.70× | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | 1.18× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
